Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 10)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
6-Feb-10 Reuters Investment Profile N/A Imagelinx Plc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
6-Feb-10 Reuters Investment Profile N/A Interleukin Genetics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ILI: the economy's impact on ILI's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
1-Feb-10 Graham & Whiteside Limited Graham & Whiteside UK - Public SERVICES Companies - Graham & Whiteside listing 171 $440 View Abstract
31-Jan-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Interleukin Genetics, Inc. 42 $65 View Abstract
5-Jan-10 Global Markets Direct Global Markets Direct Interleukin Genetics Incorporated Financial and Strategic Analysis Review 40 $300 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Industry Report for BIOTECHNOLOGY 18 $49 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for ILI 13 $25 View Abstract
28-Mar-09 Pechala's Reports Frantisek Pechala INTERLEUKIN GENETICS INC (ILI=US) 12-months forecast 1 $15 View Abstract
28-Mar-09 Pechala's Reports Lubomir Pechala INTERLEUKIN GENETICS INC (ILI=US) 2-weeks forecast 1 $10 View Abstract

Independent Reports (Showing 1 to 10 of 10)

Release
Date Contributor Author Title Pages Price More Info
6-Feb-10 Reuters Investment Profile N/A Imagelinx Plc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
6-Feb-10 Reuters Investment Profile N/A Interleukin Genetics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ILI: the economy's impact on ILI's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
1-Feb-10 Graham & Whiteside Limited Graham & Whiteside UK - Public SERVICES Companies - Graham & Whiteside listing 171 $440 View Abstract
31-Jan-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Interleukin Genetics, Inc. 42 $65 View Abstract
5-Jan-10 Global Markets Direct Global Markets Direct Interleukin Genetics Incorporated Financial and Strategic Analysis Review 40 $300 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Industry Report for BIOTECHNOLOGY 18 $49 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for ILI 13 $25 View Abstract
28-Mar-09 Pechala's Reports Frantisek Pechala INTERLEUKIN GENETICS INC (ILI=US) 12-months forecast 1 $15 View Abstract
28-Mar-09 Pechala's Reports Lubomir Pechala INTERLEUKIN GENETICS INC (ILI=US) 2-weeks forecast 1 $10 View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.